Ginkgo biloba is a monotypic species native to China with great economic and ecological values. Leaves extract of this tree contains about 24% flavonoids, which are widely used in the pharmaceutical industry. However, the flavonoids biosynthesis pathway is poorly understood in Ginkgo. In this study, we comprehensively compared the transcriptome and metabolite profiles of Ginkgo high-flavonoids mutant (ZY1) and Anlu1 (control) leaves. A total of 122 significantly changed metabolites and 1683 differentially expressed genes (DEGs), including 45 transcription factors, were identified in ZY1 compared to those in Anlu1. An integrated analysis of metabolic and transcriptomic data revealed that the abundances of some major flavonoids (especially flavone and flavonol) were most significantly increased, while other phenylpropanoid-derived products and lipids showed the most largely reduced abundances in ZY1 compared to those in Anlu1. Quantitative real-time polymerase chain reaction results confirmed the alterations in the expression levels of genes encoding components of pathways involved in phenylpropanoids and lipids. The redirection of metabolic flux may contribute to increased accumulation of flavonoid levels in ZY1 leaves. Our results provide valuable information for metabolic engineering of Ginkgo flavonoids biosynthesis.
Keywords: Ginkgo biloba; flavonoids biosynthesis; metabolomics; phenylpropanoids metabolic flux; transcriptomics.